Gist
- Study site by treatment interaction is often the interaction that is worried about the most in multi-center randomized clinical trials, because regulatory agencies are concerned with consistency of treatment effects over study centers. However, this type of interaction is usually the weakest and is difficult to assess when there are many centers due to the number of interaction parameters to estimate. Schemper545 discusses various types of interactions and a general nonparametric test for interaction.
R